Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEXAS: Tranexamic Acid in POP Surgery
NCT06419075Phase 4Withdrawn
- Sponsor
- The University of Texas Medical Branch at Galveston
- Start
- Jul 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of tranexamic acid in pelvic organ prolapse (POP), sponsored by The University of Texas Medical Branch at Galveston. Primary endpoint: Intraoperative quantitative blood loss. Planned start Jul 2024; status: withdrawn.
02
Drugs
tranexamic acid
03
Conditions
pelvic organ prolapse (POP)
Beyond the preview
Go deeper on NCT06419075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06419075.